Taiwan · Delayed Price · Currency is TWD Pet Pharm Biotech Statistics
Total Valuation
TPEX:7762 has a market cap or net worth of TWD 2.83 billion. The enterprise value is 2.44 billion.
| Market Cap | 2.83B |
| Enterprise Value | 2.44B |
Important Dates
The next estimated earnings date is Tuesday, April 21, 2026.
| Earnings Date | Apr 21, 2026 |
| Ex-Dividend Date | Aug 25, 2025 |
Share Statistics
TPEX:7762 has 57.23 million shares outstanding. The number of shares has increased by 32.26% in one year.
| Current Share Class | 57.23M |
| Shares Outstanding | 57.23M |
| Shares Change (YoY) | +32.26% |
| Shares Change (QoQ) | +11.55% |
| Owned by Insiders (%) | 10.37% |
| Owned by Institutions (%) | 3.01% |
| Float | 39.62M |
Valuation Ratios
The trailing PE ratio is 107.61.
| PE Ratio | 107.61 |
| Forward PE | n/a |
| PS Ratio | 12.76 |
| PB Ratio | 2.37 |
| P/TBV Ratio | 2.62 |
| P/FCF Ratio | 591.57 |
| P/OCF Ratio | 82.61 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 51.16, with an EV/FCF ratio of 509.91.
| EV / Earnings | 97.74 |
| EV / Sales | 11.00 |
| EV / EBITDA | 51.16 |
| EV / EBIT | 165.62 |
| EV / FCF | 509.91 |
Financial Position
The company has a current ratio of 10.68, with a Debt / Equity ratio of 0.09.
| Current Ratio | 10.68 |
| Quick Ratio | 10.28 |
| Debt / Equity | 0.09 |
| Debt / EBITDA | 2.22 |
| Debt / FCF | 22.17 |
| Interest Coverage | 16.53 |
Financial Efficiency
Return on equity (ROE) is 2.80% and return on invested capital (ROIC) is 0.91%.
| Return on Equity (ROE) | 2.80% |
| Return on Assets (ROA) | 0.87% |
| Return on Invested Capital (ROIC) | 0.91% |
| Return on Capital Employed (ROCE) | 1.14% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | 4.93M |
| Profits Per Employee | 555,222 |
| Employee Count | 45 |
| Asset Turnover | 0.21 |
| Inventory Turnover | 7.46 |
Taxes
| Income Tax | -723,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -10.87% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -10.87% |
| 50-Day Moving Average | 59.31 |
| 200-Day Moving Average | 66.36 |
| Relative Strength Index (RSI) | 27.56 |
| Average Volume (20 Days) | 73,588 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, TPEX:7762 had revenue of TWD 222.03 million and earned 24.99 million in profits. Earnings per share was 0.46.
| Revenue | 222.03M |
| Gross Profit | 116.44M |
| Operating Income | 14.74M |
| Pretax Income | 24.17M |
| Net Income | 24.99M |
| EBITDA | 38.19M |
| EBIT | 14.74M |
| Earnings Per Share (EPS) | 0.46 |
Balance Sheet
The company has 518.86 million in cash and 106.16 million in debt, with a net cash position of 412.70 million or 7.21 per share.
| Cash & Cash Equivalents | 518.86M |
| Total Debt | 106.16M |
| Net Cash | 412.70M |
| Net Cash Per Share | 7.21 |
| Equity (Book Value) | 1.20B |
| Book Value Per Share | 20.51 |
| Working Capital | 544.30M |
Cash Flow
In the last 12 months, operating cash flow was 34.30 million and capital expenditures -29.51 million, giving a free cash flow of 4.79 million.
| Operating Cash Flow | 34.30M |
| Capital Expenditures | -29.51M |
| Depreciation & Amortization | 23.45M |
| Net Borrowing | -107.80M |
| Free Cash Flow | 4.79M |
| FCF Per Share | 0.08 |
Margins
Gross margin is 52.44%, with operating and profit margins of 6.64% and 11.25%.
| Gross Margin | 52.44% |
| Operating Margin | 6.64% |
| Pretax Margin | 10.89% |
| Profit Margin | 11.25% |
| EBITDA Margin | 17.20% |
| EBIT Margin | 6.64% |
| FCF Margin | 2.16% |
Dividends & Yields
This stock pays an annual dividend of 0.25, which amounts to a dividend yield of 0.51%.
| Dividend Per Share | 0.25 |
| Dividend Yield | 0.51% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 20.22% |
| Buyback Yield | -32.26% |
| Shareholder Yield | -31.75% |
| Earnings Yield | 0.88% |
| FCF Yield | 0.17% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on August 25, 2025. It was a forward split with a ratio of 1.013420847.
| Last Split Date | Aug 25, 2025 |
| Split Type | Forward |
| Split Ratio | 1.013420847 |
Scores
TPEX:7762 has an Altman Z-Score of 13.21 and a Piotroski F-Score of 6.
| Altman Z-Score | 13.21 |
| Piotroski F-Score | 6 |